123 related articles for article (PubMed ID: 7620835)
1. Effect of losartan, an AT1 selective angiotensin II receptor antagonist, on isoproterenol-induced cardiac ornithine decarboxylase activity.
Nakano M; Kanda T; Matsuzaki S; Hasegawa S; Ma H; Imai S; Suzuki T; Kobayashi I
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):21-30. PubMed ID: 7620835
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
3. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
Cody RJ; Binkley PF; Haas GJ; Brown DM
Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227
[TBL] [Abstract][Full Text] [Related]
4. Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan.
Hajj-Ali AF; Wong PC
J Pharmacol Exp Ther; 1993 Dec; 267(3):1423-7. PubMed ID: 7903389
[TBL] [Abstract][Full Text] [Related]
5. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
Dahlöf B
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
[TBL] [Abstract][Full Text] [Related]
6. [Angiotensin receptors in the rat myocardium during pre- and postnatal development].
Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
Cardiologia; 1993 Jul; 38(7):471-6. PubMed ID: 8221742
[TBL] [Abstract][Full Text] [Related]
7. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors].
Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
Cardiologia; 1993 Aug; 38(8):519-23. PubMed ID: 8313407
[TBL] [Abstract][Full Text] [Related]
8. The angiotensin II subtype 2 (AT2) receptor is linked to protein kinase C but not cAMP-dependent pathways in the cardiomyocyte.
Rabkin SW
Can J Physiol Pharmacol; 1996 Feb; 74(2):125-31. PubMed ID: 8723023
[TBL] [Abstract][Full Text] [Related]
9. The diversified pharmacology of angiotensin II-receptor blockade.
Timmermans PB; Smith RD
Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
[TBL] [Abstract][Full Text] [Related]
10. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
11. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
[TBL] [Abstract][Full Text] [Related]
12. Discovery of losartan, the first angiotensin II receptor antagonist.
Timmermans PB; Duncia JV; Carini DJ; Chiu AT; Wong PC; Wexler RR; Smith RD
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
O'Sullivan JB; Black MJ; Bertram JF; Bobik A
J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
[TBL] [Abstract][Full Text] [Related]
14. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
[TBL] [Abstract][Full Text] [Related]
15. Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
Niederberger M; Aubert JF; Nussberger J; Brunner HR; Waeber B
J Hypertens; 1995 Apr; 13(4):439-45. PubMed ID: 7629405
[TBL] [Abstract][Full Text] [Related]
16. The contribution of AT1 and AT2 angiotensin receptors to its cognitive effects.
Braszko J
Acta Neurobiol Exp (Wars); 1996; 56(1):49-54. PubMed ID: 8787210
[TBL] [Abstract][Full Text] [Related]
17. Developmental regulation of angiotensin type 1 and 2 receptor gene expression and heart growth.
Everett AD; Fisher A; Tufro-McReddie A; Harris M
J Mol Cell Cardiol; 1997 Jan; 29(1):141-8. PubMed ID: 9040029
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
Golomb E; Abassi ZA; Cuda G; Stylianou M; Panchal VR; Trachewsky D; Keiser HR
Am J Physiol; 1994 Oct; 267(4 Pt 2):H1496-506. PubMed ID: 7524366
[TBL] [Abstract][Full Text] [Related]
19. Ontogeny of cardiac ornithine decarboxylase and its beta adrenergic responsiveness in the rat.
Miska SP; Kimmel GL; Harmon JR; Webb P
J Pharmacol Exp Ther; 1984 Aug; 230(2):419-23. PubMed ID: 6086887
[TBL] [Abstract][Full Text] [Related]
20. Effect of nonpeptide angiotensin AT-1 and AT-2 antagonists on isoproterenol-induced renin release.
Rowland NE; Fregly MJ
Pharmacol Biochem Behav; 1993 Mar; 44(3):623-6. PubMed ID: 8451266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
